Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue
β Scribed by Yoshiya Z. Inoue; Frank J. Frassica; Franklin H. Sim; K. Krishnan Unni; Ivy A. Petersen; Richard A. McLeod
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 298 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background and Objectives: Modern series of adult extremity soft tissue sarcomas utilize combinations of modalities in all patients. Remaining questions: 1) is it necessary to strive for wide margins in the multimodality era; 2) to use adjuvant therapy in every high-grade sarcoma? 3) Does previous p
Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con
BACKGROUND. Soft tissue sarcomas (STS) are a heterogeneous group of neoplasms whose etiology remains largely undefined. A role for female hormones in the development of STS has been suggested. To investigate this possibility, the authors analyzed data from a hospital-based case-control study conduct